NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT03180294 2026-05-19Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerNRG OncologyPhase 2 Completed230 enrolled 24 charts